Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Aguulp innovates and curates liquid formulas using liposomal technology. The company asserts that vitamins in pill form have an absorption rate as low as 5% which is further eaten by stomach acid upon consumption before a person gets a chance to absorb it. Agullp aims to resolve this. Its product, NutriProtect, shields nutrients from corrosive stomach acid and helps 98% of nutrients reach the small intestine for absorption. The company estimates that over 3 million people in the UK and more than 10 per cent of the world’s population is malnourished for a variety of reasons, including environmental pollution, unhealthy diets and stressful lifestyles that block nutrient absorption and compound deficiencies. Aguulp aims to change this with its product line that includes Aguulp for Gut, Aguulp for Brain, and Aguulp for Immunity. The company will use 55.6% of the investment for marketing purposes, 44.2% for paying their staff, and 0.2% as other expenses.
days to go:
Expired
investment:
£317,993
Six to Start are the co-creators of the popular fitness game 'Zombies, run!' and are now raising investment to grow this and to also build a new app called 'Virtual Races.' With over 3,000,000 downloads and peaks of 250k monthly active users, Zombie, Run! brings together audio storytelling and gameplay with real-world exercise. Virtual Races has already attracted over 15,000 entrants and generated over £600K+ in revenue.
days to go:
Expired
investment:
£249,970
Catipilla designs, manufactures and retails a range of high quality, functional, wall-mounted climbing frames, resting points, and scratchers to create unique living spaces for cats. The company asserts that the cat segment of the pet market is worth an estimated £5 billion in the UK alone. It wants to become a contender in this segment. Catipilla has sold 2,000+ products across 16 countries, listed at retailer Pets at Home, and became a finalist in the PetQuip '2018 Product of the Year' in the past three years. Catipilla's products are situated in vet practices, catteries, and cat rescue centres. The company claims that it is endorsed by International Cat Care and has a partnership with IAMS, a global pet food giant. After a 5.36 times increase in orders during the 2020 lockdown (compared to Q2 and Q3 2019), Catipilla requires investment to scale up sales, distribution, manufacturing, and export capability.
days to go:
Expired
investment:
£196,702
Based in London, Several is a menswear brand with firm roots in British sub-culture. Several's clothing focuses on quality, craftsmanship, and luxury. The funds raised will be used to open a store in London and to grow sales.
days to go:
Expired
investment:
£7,350
Fishy Filaments (FF) has developed a fishing net recycling process that enables immediate use of net materials in 3D printing and injection moulding. FF cites EU research stating that just 1.5% of used fishing nets are recycled. FF aims to increase the aforementioned percentage via its technology. FF argues that its proprietary fishing net recycling process fits in a standard shipping container enabling commercial fleets or local stakeholders to manage their net wastes at a profit and access a low carbon raw material from which new products can be made. FF claims that it has recycled and sold around 2 tonnes of nets to over 200 customers in over 20 countries since the brand's commercial launch in January 2019. Its product, Marine Nylon, has been met with interest from customers and investors alike. FF will use the investment to diversify its product range and come up with solutions that help protect the world's oceans and coastal communities from plastic waste.
days to go:
Expired
investment:
£221,479
Hagley West is an online watch company co-owned by cricketing legend, Chris Gayle. The brand has more than 50,000 followers on Social Media and has already sold its products in 39 different countries. To eliminate high barriers constructed by big brand markups and sales agents, Hagley West has developed a strategy to deliver direct to the consumer. Hagley West aims at increasing its presence to billions of global cricket fans with growth plans focused in the Asian market. With the proceeds, the company will accelerate its core business, develop new ranges, and expand into new markets.
days to go:
Expired
investment:
£353,540
